Trudie Lang | Academic Influence

Trudie Lang's AcademicInfluence.com Rankings

Trudie Lang

Computer Science

#11784

World Rank

#12537

Historical Rank

Machine Learning

#5720

World Rank

#5799

Historical Rank

Artificial Intelligence

#6169

World Rank

#6265

Historical Rank

Database

#8874

World Rank

#9324

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Trudie Lang's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Trudie Lang Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Trudie Lang is a Professor of Global Health Research at the University of Oxford. She specialises in clinical trials research capacity building in low-resource setting, and helped to organise the trial for the drug brincidofovir during the 2014 Ebola virus outbreak.

(See a Problem?)

Trudie Lang's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mortality after fluid bolus in African children with severe infection. (2011) (1069)
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. (2012) (689)
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (2011) (531)
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. (2008) (421)
Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature (2017) (192)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. (2008) (172)
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial (2011) (172)
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya (2006) (157)
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial (2016) (141)
Clinical Trials Have Gone Global: Is This a Good Thing? (2012) (108)
The Induction and Persistence of T Cell IFN-γ Responses after Vaccination or Natural Exposure Is Suppressed by Plasmodium falciparum1 (2007) (93)
Global health trials methodological research agenda: results from a priority setting exercise (2018) (89)
Advancing Global Health Research Through Digital Technology and Sharing Data (2011) (84)
Experimental Treatment of Ebola Virus Disease with Brincidofovir (2016) (82)
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform (2015) (80)
Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya (2007) (76)
The development of Lapdap, an affordable new treatment for malaria. (2003) (72)
Use of deferred consent for severely ill children in a multi-centre phase III trial (2011) (71)
Clinical Research in Resource-Limited Settings: Enhancing Research Capacity and Working Together to Make Trials Less Complicated (2010) (69)
The challenges and opportunities of conducting a clinical trial in a low resource setting: The case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial (2011) (63)
Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease (2015) (55)
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area. (2006) (53)
Strengthening the Informed Consent Process in International Health Research through Community Engagement: The KEMRI-Wellcome Trust Research Programme Experience (2011) (51)
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine (2011) (49)
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya. (2006) (49)
Big Data in Healthcare (2017) (48)
Could an Open-Source Clinical Trial Data-Management System Be What We Have All Been Looking For? (2008) (47)
Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka (2017) (45)
Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis in northern Ethiopia (GoLBeT): a pragmatic randomised controlled trial (2018) (45)
Clinical research: time for sensible global guidelines (2011) (36)
Early Gamma Interferon and Interleukin-2 Responses to Vaccination Predict the Late Resting Memory in Malaria-Naïve and Malaria-Exposed Individuals (2006) (33)
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men. (2006) (31)
The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19 (2020) (30)
Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia (2013) (30)
Global outbreak research: harmony not hegemony (2020) (28)
Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area. (2007) (28)
Alternating vector immunizations encoding pre‐erythrocytic malaria antigens enhance memory responses in a malaria endemic area (2006) (28)
Adaptive Trial Design: Could We Use This Approach to Improve Clinical Trials in the Field of Global Health? (2011) (27)
Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children (2010) (26)
Beyond registration--measuring the public-health potential of new treatments for malaria in Africa. (2006) (25)
ZikaPLAN: Zika Preparedness Latin American Network (2017) (25)
Podoconiosis treatment in northern Ethiopia (GoLBet): study protocol for a randomised controlled trial (2015) (22)
Ebola: Embed research in outbreak response (2015) (21)
A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers (2011) (21)
Using big data analytics to extract disease surveillance information from point of care diagnostic machines (2017) (20)
Trial design for evaluating novel treatments during an outbreak of an infectious disease (2016) (17)
ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas (2019) (14)
Plug COVID-19 research gaps in detection, prevention and care (2020) (14)
Clinical Epidemiology and Global Health (2018) (14)
Experience of using an open source clinical trials data management software system in Kenya (2014) (14)
The Schistosomiasis Clinical Trials Landscape: A Systematic Review of Antischistosomal Treatment Efficacy Studies and a Case for Sharing Individual Participant-Level Data (IPD) (2016) (14)
A research methodology study to map the process of initiating and operating a randomised controlled trial of podoconiosis treatment in Northern Ethiopia (2013) (13)
Ebola: Europe-Africa research collaborations. (2015) (12)
Data safety and monitoring boards for African clinical trials. (2008) (12)
Developing a globally applicable evidence-informed competency framework to support capacity strengthening in clinical research (2017) (12)
Barriers and enablers of locally led clinical trials in Ethiopia and Cameroon: a prospective, qualitative study (2013) (12)
Malaria vaccine trial endpoints – bridging the gaps between trial design, public health and the next generation of vaccines (2009) (12)
A Sensible Approach To Monitoring Trials: Finding Effective Solutions In-house (2010) (11)
Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, Ethiopia (2019) (11)
Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study (2020) (10)
The COVID-19 pandemic should not derail global vector control efforts (2020) (10)
New TB vaccine granted orphan drug status (2005) (9)
Phase Iib, Randomized, Double-Blind Trial to Assess the Efficacy, Safety and Immunogenicity of the Candidate Malaria Vaccine Rts,S/As01 in Kenyan and Tanzanian Children (2008) (9)
It is not enough that we require data to be shared; we have to make sharing easy, feasible and accessible too! (2019) (9)
Strengthening Neglected Tropical Disease Research through Enhancing Research-Site Capacity: An Evaluation of a Novel Web Application to Facilitate Research Collaborations (2014) (7)
Intersection of geospatial big data, geocomputation and cloud computing (2015) (7)
Data Science and Analytics (2017) (7)
A QUALITATIVE STUDY OF BARRIERS AND ENABLERS TO THE ESTABLISHMENT OF ROBUST CLINICAL RESEARCH DATA MANAGEMENT SYSTEMS IN LOW AND MIDDLE INCOME COUNTRIES (2018) (4)
An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol (2018) (4)
International health research monitoring: exploring a scientific and a cooperative approach using participatory action research (2014) (3)
Measuring research capacity development in healthcare workers: a systematic review (2021) (3)
The legacy of ZikaPLAN: a transnational research consortium addressing Zika (2021) (3)
Safety, immunogenicity and efficacy studies of candidate malaria vaccines FP9 and MVA encoding ME-TRAP in Kenyan children [MIM-PB-224908] (2005) (2)
THE ACT CONSORTIUM AND THE GLOBAL HEALTH NETWORK: COLLABORATING TO PROVIDE AN ONLINE, OPEN-ACCESS, COMPREHENSIVE PHARMACOVIGILANCE RESOURCE FOR THOSE WORKING IN TROPICAL INFECTIOUS DISEASES AND GLOBAL HEALTH (2017) (2)
Diverse Ethics of Translational Research in the Developing World (2010) (2)
Excess mortality among people with podoconiosis: secondary analysis of two Ethiopian cohorts (2020) (2)
Developing a global core competency framework for clinical research (2015) (1)
Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children (2010) (1)
Big Data and Big Data Technologies (2017) (1)
Engaging local health research communities to enhance long-term capacity building in Brazil (2021) (1)
Experience of using an open source clinical trials data management software system in Kenya (2014) (1)
International Health and Tropical Medicine 08: Proceedings of a Residential Meeting of the Royal Society of Tropical Medicine and Hygiene, 17-19 September 2008, Brighton, UK. (2009) (1)
Facilitating research into research using SWAR (Studies Within A Review) and SWAT (Studies Within A Trial). (2014) (1)
Sharing methods for global health research: an assessment of methodology (2013) (1)
Setting up a pragmatic clinical trial in a low-resource setting: A qualitative assessment of GoLBeT, a trial of podoconiosis management in Northern Ethiopia (2021) (1)
Lessons from coronavirus disease 2019 (COVID-19) testing strategies in three lusophone countries (2021) (1)
SYSTEMATIC REVIEW OF ANTISCHISTOSOMAL TREATMENT EFFICACY STUDIES AND THE SIGNIFICANCE OF INDIVIDUALLEVEL PARTICIPANT DATA FOR META-ANALYSES (2017) (1)
Building a data-sharing platform for schistosomiasis treatment data: opportunities and challenges (2015) (0)
falciparum Plasmodium Exposure Is Suppressed by Responses after Vaccination or Natural γ The Induction and Persistence of T Cell IFN-and (2007) (0)
Introducing 'global health methodology research' a knowledge sharing platform open to all (2013) (0)
Chapter 2 Data Science and Analytics (2017) (0)
Lymphoedema management in podoconiosis (2018) (0)
New TB vaccine granted orphan drug status. Author's reply (2005) (0)
Investigating the Secondary Use of Clinical Research Data: Protocol for a Mixed Methods Study (2022) (0)
Is Suppressed by Responses after Vaccination or Natural Exposure γ The Induction and Persistence of T Cell IFN (2011) (0)
HARNESSING THE DIGITAL SHARING REVOLUTION TO DRIVE GLOBAL HEALTH RESEARCH: SHOWING SIGNIFICANT IMPACT THAT SHOULD SUPPORT EDCTP CAPACITY DEVELOPMENT (2017) (0)
The remaining unknowns: A determination of the current research priorities for COVID-19 by the global health research community (2020) (0)
VARIABILITY IN CLINICAL RESEARCH DATA MANAGEMENT PRACTICES: LESSONS FROM THE MALARIA COMMUNITY (2017) (0)
Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children (2010) (0)
PO 8529 INTRODUCING A UNIQUE RESEARCH CAPACITY DEVELOPMENT PLATFORM SUPPORTING PREPAREDNESS FOR EFFECTIVELY COMBATING EPIDEMIC OUTBREAKS (2019) (0)
Appendix 5 – Sources of Information in Tropical Medicine (2014) (0)
Vector control to eliminate artemisinin resistant malaria in the Greater Mekong subregion (2014) (0)
AN OPEN SOURCE PLATFORM FOR THE DEVELOPMENT OF CLINICAL TRIAL PROTOCOLS FOR POVERTY-RELATED DISEASES (2018) (0)
Strengthening research ethics governance and regulatory oversight in Central America and the Dominican Republic in response to the COVID-19 pandemic: a qualitative study (2022) (0)
Using a consensus technique for improving the methodology of clinical trials assessing treatments for Cutaneous Leishmaniasis (2015) (0)
Using digital technology to support and enhance clinical trials in resource-limited settings (2012) (0)
Big Data Analytics for Extracting Disease Surveillance Information: An Untapped Opportunity (2017) (0)
ACHIEVEMENTS AND PRIMED PROSPECTS OF INCREASING CAPABILITIES FOR MULTISITE CLINICAL TRIALS IN THE EASTERN AFRICA NETWORK OF EXCELLENCE (2017) (0)
The importance of technology in global health trials (2011) (0)
The European & Developing Countries Clinical Trials Partnership (EDCTP) Knowledge Hub: developing an open platform for facilitating high-quality clinical research (2022) (0)
THE ROADS AHEAD ... USING STRATEGIC ANALYSIS IN THE DEVELOPMENT OF ROAD STRATEGIES (1998) (0)
Developing a deployable vaccine for Africa [MIM-TL-0] (2005) (0)
Creating equity in health research to drive more and better evidence (2022) (0)
Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis (GoLBeT): a pragmatic randomised controlled trial in northern Ethiopia (2018) (0)
Enabling evidence to tackle everyday diseases to mitigate another pandemic (2022) (0)
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
COLLABORATION IS CRUCIAL; DELIVERING RESEARCH SKILLS TRAINING TO THOSE WHO NEED IT THE MOST (2017) (0)
BLENDED-LEARNING USING THE GLOBAL HEALTH NETWORK ONLINE RESOURCES: A PILOT STUDY (2017) (0)
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa1 (2012) (0)

This paper list is powered by the following services:

Other Resources About Trudie Lang

en.wikipedia.org

What Schools Are Affiliated With Trudie Lang?

Trudie Lang is affiliated with the following schools: